Investors will be nervously sorting through the aftermath of a short-lived rebellion that's seen leaving Russian…
Author: Arthur Bleemer
Apollo leads big debt investment in chip maker Wolfspeed: reports
Apollo Global Management is leading a group of lenders making a debt investment of as much…
‘We’re very upset!’ We gave a friend $400 concert tickets and $2,000 Rangers seats, but weren’t invited to his wedding. Do we speak up?
‘My theory is that the girlfriend isn't a big fan of mine. However, if she didn't…
‘The war on remote work is not over.’ But one group in particular is heading back to the office.
There are growing disparities in the return-to-office tug-of-war, according to a yearly survey of how Americans…
Why the ‘easy money’ has been made in the stock-market rally — and what comes next
The 2023 stock-market rally hits a pause. Here's what will determine where it goes from here.
Rebellion in Russia could trigger selloff in U.S. stocks and flight to safe assets, analysts say. Here’s what investors should know.
Market observers say investors could see a flight to perceived safer assets depending on how the…
I’m looking for a place that has year-round mild, sunny weather and is near or on the water, and my budget is $125,000 — where should I retire?
Looking for ideas on the best place for you to retire? Email HelpMeRetire@marketwatch.com.
Tech companies scaled back ‘diversity, equity and inclusion’ teams last year amid backlash, report says
One in five hiring managers in a new survey said their companies' diversity, equity and inclusion…
Despite high prices, Americans are looking at pricier dining options — and other fun events
Between March 2021 and March 2022, Americans started looking for more dining and entertainment options. That…
Nearly 22 million households spend more than they can afford on rent, Harvard report says
Low-income households and households of color are especially affected.
Is this all there is? How to plan a more satisfying retirement.
Think beyond things like travel or golf. If you can find three supportive elements in daily…
Sagimet Biosciences gives going public a second chance under new CEO
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing…